KRN-7000(S34)
DC67239
View product →
TLR7/8 agonist 3 is a potent TLR7 and TLR8 agonist, extracted from patent WO2016057618 (compound of formula (II))1.
| CAS No. | 642473-95-8 |
| Chemical Name | TLR7/8 agonist 3 |
| Synonyms | TLR7/8 agonist 3;1-(2-amino-2-methylpropyl)-2-(ethoxymethyl)imidazo[4,5-c]quinolin-4-amine;1-(2-amino-2-methylpropyl)-2-(ethoxymethyl)-1H-imidazo[4,5-c]quinolin-4-amine;1-(2-amino-2-methylpropyl)-2-(ethoxymethyl)-1H-imidazo[4,5-c]quinoline-4-amine |
| SMILES | O(C([H])([H])C([H])([H])[H])C([H])([H])C1=NC2C(N([H])[H])=NC3=C([H])C([H])=C([H])C([H])=C3C=2N1C([H])([H])C(C([H])([H])[H])(C([H])([H])[H])N([H])[H] |
| Formula | C17H23N5O |
| M.Wt | 313.3974 |
| Purity | >98% |
| Storage | 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
| Shipping condition | Ships from Shanghai; packaging confirmed at order. |
| Publication | 1. Martha A. MILLER, et al. Vaccine compositions and methods of use to treat neonatal subjects. |
| Product classification | Adjuvant Molecules |
The product molecular weight is prefilled when available and remains editable. Confirm solvent compatibility and solubility before preparation.
Solvent volumes update from the molecular weight above.
| Mass | 1 mM | 5 mM | 10 mM |
|---|---|---|---|
| 10 mg | 31.9084 mL | 6.3817 mL | 3.1908 mL |
| 25 mg | 79.7709 mL | 15.9542 mL | 7.9771 mL |
| 50 mg | 159.5418 mL | 31.9084 mL | 15.9542 mL |
| 100 mg | 319.0837 mL | 63.8167 mL | 31.9084 mL |
| 250 mg | 797.7092 mL | 159.5418 mL | 79.7709 mL |
Contact our team with the catalog number and requested quantity.